State Street Corp Opgen Inc Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.17 - $2.8 $21,964 - $361,760
-129,200 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.72 - $1.11 $3,816 - $5,883
5,300 Added 4.28%
129,200 $97,000
Q3 2021

Nov 15, 2021
BUY
$2.18 - $3.58 $49,922 - $81,982
22,900 Added 22.67%
123,900 $357,000
Q2 2021

Aug 16, 2021
BUY
$1.95 - $2.8 $196,950 - $282,800
101,000 New
101,000 $229,000

Others Institutions Holding OPGN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About OPGEN INC

OPGN Quotes by TradingView
  • Ticker OPGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,698,500
  • Market Cap $80.5M
  • Description
  • OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...
More about OPGN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email